-
Je něco špatně v tomto záznamu ?
Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional study
LM. Fleuren, LF. Roggeveen, T. Guo, P. Waldauf, PHJ. van der Voort, RJ. Bosman, EL. Swart, ARJ. Girbes, PWG. Elbers,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
80-83600-98-40050
ZonMw - International
NLK
BioMedCentral
od 1997-04-01
BioMedCentral Open Access
od 1997
Directory of Open Access Journals
od 1998
Free Medical Journals
od 1997
PubMed Central
od 1997
Europe PubMed Central
od 1997
ProQuest Central
od 2015-01-01
Open Access Digital Library
od 1997-01-01
Open Access Digital Library
od 1997-08-01
Open Access Digital Library
od 1998-01-01
Medline Complete (EBSCOhost)
od 2011-02-01
Health & Medicine (ProQuest)
od 2015-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1997
Springer Nature OA/Free Journals
od 1997-04-01
- MeSH
- antibakteriální látky aplikace a dávkování farmakokinetika terapeutické užití MeSH
- dospělí MeSH
- jednotky intenzivní péče organizace a řízení statistika a číselné údaje MeSH
- klinické kompetence normy statistika a číselné údaje MeSH
- kritický stav terapie MeSH
- lidé středního věku MeSH
- lidé MeSH
- monitorování léčiv metody MeSH
- průřezové studie MeSH
- průzkumy a dotazníky MeSH
- sepse farmakoterapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Antibiotic exposure in intensive care patients with sepsis is frequently inadequate and is associated with poorer outcomes. Antibiotic dosing is challenging in the intensive care, as critically ill patients have altered and fluctuating antibiotic pharmacokinetics that make current one-size-fits-all regimens unsatisfactory. Real-time bedside dosing software is not available yet, and therapeutic drug monitoring is typically used for few antibiotic classes and only allows for delayed dosing adaptation. Thus, adequate and timely antibiotic dosing continues to rely largely on the level of pharmacokinetic expertise in the ICU. Therefore, we set out to assess the level of knowledge on antibiotic pharmacokinetics among these intensive care professionals. METHODS: In May 2018, we carried out a cross-sectional study by sending out an online survey on antibiotic dosing to more than 20,000 intensive care professionals. Questions were designed to cover relevant topics in pharmacokinetics related to intensive care antibiotic dosing. The preliminary pass mark was set by members of the examination committee for the European Diploma of Intensive Care using a modified Angoff approach. The final pass mark was corrected for clinical relevance as assessed for each question by international experts on pharmacokinetics. RESULTS: A total of 1448 respondents completed the survey. Most of the respondents were intensivists (927 respondents, 64%) from 97 countries. Nearly all questions were considered clinically relevant by pharmacokinetic experts. The pass mark corrected for clinical relevance was 52.8 out of 93.7 points. Pass rates were 42.5% for intensivists, 36.1% for fellows, 24.8% for residents, and 5.8% for nurses. Scores without correction for clinical relevance were worse, indicating that respondents perform better on more relevant topics. Correct answers and concise clinical background are provided. CONCLUSIONS: Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient. This should be addressed given the importance of adequate antibiotic exposure in critically ill patients with sepsis. Solutions include improved education, intensified pharmacy support, therapeutic drug monitoring, or the use of real-time bedside dosing software. Questions may provide useful for teaching purposes.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19044814
- 003
- CZ-PrNML
- 005
- 20200113081334.0
- 007
- ta
- 008
- 200109s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13054-019-2438-1 $2 doi
- 035 __
- $a (PubMed)31118061
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Fleuren, Lucas M $u Department of Intensive Care Medicine, Research VUmc Intensive Care (REVIVE), Amsterdam Medical Data Science (AMDS), Amsterdam Cardiovascular Sciences (ACS), Amsterdam Infection and Immunity Institute (AI&II), Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. l.fleuren@vumc.nl.
- 245 10
- $a Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional study / $c LM. Fleuren, LF. Roggeveen, T. Guo, P. Waldauf, PHJ. van der Voort, RJ. Bosman, EL. Swart, ARJ. Girbes, PWG. Elbers,
- 520 9_
- $a BACKGROUND: Antibiotic exposure in intensive care patients with sepsis is frequently inadequate and is associated with poorer outcomes. Antibiotic dosing is challenging in the intensive care, as critically ill patients have altered and fluctuating antibiotic pharmacokinetics that make current one-size-fits-all regimens unsatisfactory. Real-time bedside dosing software is not available yet, and therapeutic drug monitoring is typically used for few antibiotic classes and only allows for delayed dosing adaptation. Thus, adequate and timely antibiotic dosing continues to rely largely on the level of pharmacokinetic expertise in the ICU. Therefore, we set out to assess the level of knowledge on antibiotic pharmacokinetics among these intensive care professionals. METHODS: In May 2018, we carried out a cross-sectional study by sending out an online survey on antibiotic dosing to more than 20,000 intensive care professionals. Questions were designed to cover relevant topics in pharmacokinetics related to intensive care antibiotic dosing. The preliminary pass mark was set by members of the examination committee for the European Diploma of Intensive Care using a modified Angoff approach. The final pass mark was corrected for clinical relevance as assessed for each question by international experts on pharmacokinetics. RESULTS: A total of 1448 respondents completed the survey. Most of the respondents were intensivists (927 respondents, 64%) from 97 countries. Nearly all questions were considered clinically relevant by pharmacokinetic experts. The pass mark corrected for clinical relevance was 52.8 out of 93.7 points. Pass rates were 42.5% for intensivists, 36.1% for fellows, 24.8% for residents, and 5.8% for nurses. Scores without correction for clinical relevance were worse, indicating that respondents perform better on more relevant topics. Correct answers and concise clinical background are provided. CONCLUSIONS: Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient. This should be addressed given the importance of adequate antibiotic exposure in critically ill patients with sepsis. Solutions include improved education, intensified pharmacy support, therapeutic drug monitoring, or the use of real-time bedside dosing software. Questions may provide useful for teaching purposes.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a antibakteriální látky $x aplikace a dávkování $x farmakokinetika $x terapeutické užití $7 D000900
- 650 _2
- $a klinické kompetence $x normy $x statistika a číselné údaje $7 D002983
- 650 _2
- $a kritický stav $x terapie $7 D016638
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a monitorování léčiv $x metody $7 D016903
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a jednotky intenzivní péče $x organizace a řízení $x statistika a číselné údaje $7 D007362
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a sepse $x farmakoterapie $7 D018805
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Roggeveen, Luca F $u Department of Intensive Care Medicine, Research VUmc Intensive Care (REVIVE), Amsterdam Medical Data Science (AMDS), Amsterdam Cardiovascular Sciences (ACS), Amsterdam Infection and Immunity Institute (AI&II), Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- 700 1_
- $a Guo, Tingjie $u Department of Intensive Care Medicine, Research VUmc Intensive Care (REVIVE), Amsterdam Medical Data Science (AMDS), Amsterdam Cardiovascular Sciences (ACS), Amsterdam Infection and Immunity Institute (AI&II), Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- 700 1_
- $a Waldauf, Petr $u Department of Anaesthesia and Intensive Care Medicine, Kralovske Vinohrady University Hospital and The Third Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a van der Voort, Peter H J $u Intensive Care, OLVG, Amsterdam, The Netherlands.
- 700 1_
- $a Bosman, Rob J $u Intensive Care, OLVG, Amsterdam, The Netherlands.
- 700 1_
- $a Swart, Eleonora L $u Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- 700 1_
- $a Girbes, Armand R J $u Department of Intensive Care Medicine, Research VUmc Intensive Care (REVIVE), Amsterdam Medical Data Science (AMDS), Amsterdam Cardiovascular Sciences (ACS), Amsterdam Infection and Immunity Institute (AI&II), Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- 700 1_
- $a Elbers, Paul W G $u Department of Intensive Care Medicine, Research VUmc Intensive Care (REVIVE), Amsterdam Medical Data Science (AMDS), Amsterdam Cardiovascular Sciences (ACS), Amsterdam Infection and Immunity Institute (AI&II), Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- 773 0_
- $w MED00006603 $t Critical care (London, England) $x 1466-609X $g Roč. 23, č. 1 (2019), s. 185
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31118061 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200113081706 $b ABA008
- 999 __
- $a ok $b bmc $g 1483083 $s 1083487
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 23 $c 1 $d 185 $e 20190522 $i 1466-609X $m Critical care $n Crit Care $x MED00006603
- GRA __
- $a 80-83600-98-40050 $p ZonMw $2 International
- LZP __
- $a Pubmed-20200109